Institut Universitaire du Cancer de Toulouse Oncopole

Toulouse, Midi-pyrenees 31059

0 studies enrolling now · 3 studies all time

What they study most

Myeloid Leukemia, Chronic, Chronic Phase, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL), Sickle Cell Disease

Studies at this site

• A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD) — Running, not enrolling
• Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses — Completed
• A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia — Running, not enrolling